Therapix Biosciences has acquired 2 companies, including 1 in the last 5 years.
Therapix Biosciences’ largest acquisition to date was in 2019, when it acquired Destiny Biosciences Global for $48M. Therapix Biosciences has acquired in 2 countries. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to Therapix Biosciences’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 1
- Total Countries Invested 2